about
A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformationMolecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancersTissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumoursEchoes of the embryo: using the developmental biology toolkit to study cancerMammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTENMolecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and TreatmentActivity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial.Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalitiesAcquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity.Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epitheliaNuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression.Risk factors for epithelial ovarian cancer by histologic subtype.Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma.Ovarian cyst fluid of serous ovarian tumors contains large quantities of the brain amino acid N-acetylaspartate.A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancerEndometriosis-associated ovarian cancer: A ten-year cohort study of women living in the Estrie Region of Quebec, CanadaPOLD2 and KSP37 (FGFBP2) correlate strongly with histology, stage and outcome in ovarian carcinomas.Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.Ovarian cancer: pathology, biology, and disease modelsThe MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.The blood-follicle barrier (BFB) in disease and in ovarian function.Clinical research device for ovarian cancer detection by optical spectroscopy in the ultraviolet C-visible.Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.Ghrelin and obestatin expression in serous ovarian tumours.Diagnosis, treatment, and follow-up of borderline ovarian tumorsThe MAPK pathway across different malignancies: a new perspective.S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.Expression proteomics predicts loss of RXR-γ during progression of epithelial ovarian cancer.Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Early inflammatory response in epithelial ovarian tumor cyst fluids.Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problemsFrequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcomeGenetic analysis of colon tumors induced by a dietary carcinogen PhIP in CYP1A humanized mice: Identification of mutation of β-catenin/Ctnnb1 as the driver gene for the carcinogenesis.Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53-null background
P2860
Q24314746-4A662C0B-98D6-423D-B5D1-30E3B36FC5B1Q24634248-E759A934-C7A9-4289-A0A8-BA48D676362EQ24651981-0E17CC44-7157-4D6A-BE3D-8D97EA67A0A0Q26770157-79DD32A8-6028-4593-B74E-4B044020EF43Q27335766-238981A0-EF75-4897-816F-870C768D663EQ28066904-6A692921-90BE-41D7-B3EA-FA5ADA5BBD62Q30429122-46F0B783-DBB4-4E44-BE26-835E0A9A0034Q33315604-7A82B08F-21EB-468A-884E-B303339EC5C7Q33431553-7A0268EB-9112-4831-8DF4-4D78DDC14F47Q33489525-9A1BEF2E-BEA5-4555-A969-0D843429F0F6Q33495389-0209D8C5-B819-456B-8B80-1DB761142886Q33552610-1EDE1503-84A1-4BC9-93A2-214412FB7724Q33562658-A182FB62-FD1C-4E85-91B8-42885DDB103BQ33565482-C129C9E7-D088-4937-8817-CD347A82B38CQ33634277-9079CF01-A5F2-4E61-9F33-BE0A710B96DDQ33657465-A561EA0E-8C3A-4BFB-A8FC-4429E543F9FAQ33747847-5E61B76D-60EB-4C14-BE69-B08F6640F079Q33775466-2B834855-B53B-458D-97A7-5292A7912F63Q33807748-D38F123D-E4D2-4AB6-918E-1D782D880F23Q33825555-A379E747-B009-4D9A-80E5-66488C51B423Q33890039-5DBB0408-31F2-41BE-BCFD-EEEA20DB4E1BQ34033619-50FC0B31-8F79-4CA6-8AD6-987F1B365763Q34162272-4984762D-DBA1-4AC3-AD0D-47303817A419Q34216518-0B80BE54-2770-49FC-B73A-5FB1A4050AC9Q34335969-FD1342C9-D534-456F-B970-C5BCFF4E5D92Q34350701-41CCF800-C90A-4747-87F6-1420CDBBDC3AQ34407204-3AADB3DE-7774-4EBF-BF69-4697791C2D61Q34424902-51474F78-F0F1-4818-927B-F70207D2866EQ34459097-23D5E95D-4990-4A27-80F1-3087F8E9A83FQ34579314-E51994DF-D3F9-40E8-B9C7-1E8491E2192EQ34925660-BBEC97B9-CF48-45B8-9085-76F50B82C71CQ34977063-4690BF32-DFD7-416E-9AB7-838AE5372516Q34998539-8C136FFE-8006-4653-9DB5-78F28BE39928Q34998994-24103E26-CBDE-45FB-8867-2346C81FAA9EQ35032772-056E24F8-D90B-4332-B8F0-DACEC21976F4Q35091509-15F60F7A-E166-42C0-A4A4-8C730A2ED91AQ35098085-5E68A044-1E8D-49A2-A803-6C693B76FC15Q35132338-E0741BA8-03C2-4703-BF2E-B0DA7F104F45Q35140600-4ACB90D4-4BEE-4883-AE2D-D2B68A2D454DQ35221856-D6BEE523-B1BA-4118-9697-B923B5782CBD
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Origins and molecular pathology of ovarian cancer.
@ast
Origins and molecular pathology of ovarian cancer.
@en
type
label
Origins and molecular pathology of ovarian cancer.
@ast
Origins and molecular pathology of ovarian cancer.
@en
prefLabel
Origins and molecular pathology of ovarian cancer.
@ast
Origins and molecular pathology of ovarian cancer.
@en
P2860
P1433
P1476
Origins and molecular pathology of ovarian cancer.
@en
P2093
Debra A Bell
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800306
P478
18 Suppl 2
P577
2005-02-01T00:00:00Z
P5875
P6179
1027289274